1 / 43

Future of Clinical Pharmacy Practice in Rural Health

Lisa Anne Boothby, PharmD , BCPS Director of Pharmacy, Dukes Memorial Hospital. Future of Clinical Pharmacy Practice in Rural Health. OBJECTIVES. Demonstrate the value of clinical pharmacy services to decrease 30-day readmission rates Outline the pharmacist’s role in reducing medical waste

terah
Télécharger la présentation

Future of Clinical Pharmacy Practice in Rural Health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lisa Anne Boothby, PharmD, BCPS Director of Pharmacy, Dukes Memorial Hospital Future of Clinical Pharmacy Practice in Rural Health

  2. OBJECTIVES • Demonstrate the value of clinical pharmacy services to decrease 30-day readmission rates • Outline the pharmacist’s role in reducing medical waste • Detail ethical issues associated with drug shortage management

  3. PHARMACEUTICAL CARE • Clinical pharmacy services • Inpatient and outpatient settings • Improve patient outcomes

  4. PHARMACISTS AS PROVIDERS • Patient Accountability and Affordable Care Act • Pharmacists are “other healthcare providers” • Social Security Act • Part B versus Part D • Three MTM billing codes • Private insurance reimbursement follows Smock N. Affordable Care Act Regards Pharmacists as Health Care Providers, Not Just Prescription Dispensers. Available at URL: http://www.pharmacytimes.com/publications/issue/2013/January2013/Affordable-Care-Act-Regards-Pharmacists-as-Health-Care-Providers-Not-Just-Prescription-Dispensers

  5. WHERE IS THE REVENUE? • Capitated healthcare precede reimbursement • May decrease need for pharmacy billing • Share in savings once minimum achieved • Accountable care organizations • Not all hospitals have embraced • Pilot programs Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

  6. ACCOUNTABLE CARE ORGANIZATION • Providersaccountable • Achieving quality • Reductions in rate of spending growth • Physician led with many payer arrangements • National Committee for Quality Assurance • Established ACO criteria • 7 categories with 4 levels Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

  7. RURAL ACOs To reach critical mass • Incorporate multiple payers or multiple hospitals • Apply for a CMS wavier to include Medicaid patients Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

  8. MEDICAL HOME MODEL • Patient centered medical homes • Led by physician • Include pharmacist, nurse and other health care practitioners • Treat patient with chronic conditions • Prevent adverse events and optimize therapy • Team ensures all health care needs are met Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

  9. PHARMACIST ROLE Medical Home Models • Improve medication management • Preventing hospital readmissions • Decreases revenue in a traditional hospital budgetary model Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

  10. AMBULATORY CARE FOCUS • Keep patients healthy and out of the hospital • VA collaborative practice model • Prescribing privileges • More than 20 years of success • Pharmacist credentialed providers

  11. PHARMACY ROLE • Medication management • Preventing disease • Maintaining cardiovascular health • Preventing end organ damage • Medication compliance, adherence • Therapeutic drug monitoring • Supportive care

  12. CLINICAL RESEARCH

  13. PHYSICIAN-PHARMACIST TEAM Study Design • 1 month study at Mission Hospital • 735 bed community teaching hospital • Asheville, North Carolina • Pre-post design • 2 weeks normal routine • 2 weeks with clinical pharmacist Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, 2013. Available at http://www.pharmacytimes.com/news/Physician-Pharmacist-Team-Improves-Hospital-Care

  14. PHYSICIAN-PHARMACIST TEAM Pharmacist Role on Team • Drug information • Discharge counseling • Medication interventions • Medication reconciliation • Filling discharge prescriptions • Submit discharge summaries Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, 2013. Available at http://www.pharmacytimes.com/news/Physician-Pharmacist-Team-Improves-Hospital-Care

  15. PHYSICIAN-PHARMACIST TEAM Measurements • 15-day and 30-day readmission rates • Number of ED visits • Employee satisfaction surveys Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, 2013. Available at http://www.pharmacytimes.com/news/Physician-Pharmacist-Team-Improves-Hospital-Care

  16. PHYSICIAN-PHARMACIST TEAM • 33% vs. 17% readmission within 30 days • 11% vs. 2% readmission within 15 days • 9% vs. 4% ED visits within 30 days Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, 2013. Available at http://www.pharmacytimes.com/news/Physician-Pharmacist-Team-Improves-Hospital-Care

  17. DISCHARGE PHARMACIST • Prospective cohort • 729 patients over three months • Pharmacy medication reconciliation • 30-day readmission rate • Polypharmacy and readmission rate Pal A. , Babbott S, and Wilkinson T. Can the use of a discharge pharmacist significantly decrease 30-day readmissions? Hospital Pharmacy 2013;48(5):380-388.

  18. READMISSION RATES Pal A. , Babbott S, and Wilkinson T. Can the use of a discharge pharmacist significantly decrease 30-day readmissions? Hospital Pharmacy 2013;48(5):380-388.

  19. DISCHARGE PHARMACIST • Med reconciliation and counseling • Decreased 30-day readmission rate • 16.8% vs. 26%; p=0.006 • Polypharmacy • More than 5 scheduled medications • Associated with increased readmission rates Pal A. , Babbott S, and Wilkinson T. Can the use of a discharge pharmacist significantly decrease 30-day readmissions? Hospital Pharmacy 2013;48(5):380-388.

  20. TRANSITIONS OF CARE

  21. WELLTRANSITIONS • Walgreens program • Reduces readmissions • Pharmacists oversee medication regimens • Transitions of care Walgreens Program Employs Pharmacists to Reduce Hospital Readmissions. November 20, 2012. http://www.pharmacytimes.com/news/Walgreens-Program-Employs-Pharmacists-to-Reduce-Hospital-Readmissions

  22. WELLTRANSITIONS • Med review at admission and discharge • Bedside medication delivery • Counseling for patients and their caregivers • Regularly scheduled follow-up post discharge • 24-7 support for discharged patients • Ensure follow up with physician • Ensure appropriate self care • Marian General and Lutheran Hospital Walgreens Program Employs Pharmacists to Reduce Hospital Readmissions. November 20, 2012. http://www.pharmacytimes.com/news/Walgreens-Program-Employs-Pharmacists-to-Reduce-Hospital-Readmissions

  23. MEDICATION RECONCILIATION Survey of Pharmacy Perceptions • 11 pharmacists • Vanderbilt University • Brigham and Women’s Hospital • Medication reconciliation • Time consuming • Most important contribution • Improving care transitions • Correct the admission medication history Haynes KT, Oberne A, Kripalani S. Pharmacists’ recommendations to improve care transitions. Ann Pharmacother 2012;46(9):1152-1159.

  24. IMPLICATIONS • Translation to a rural critical access hospital • Minimal resources • Decreased ED visits decreases admissions • Decreased revenue with traditional models • Next steps?

  25. REDUCE READMISSION TOOLS TARGETING TRANSITIONS • Project BOOST: www.hospital-medicine.org • Project RED: www.projectred.org • STAAR initiative: www.ihi.org/STAAR

  26. Demonstration Pilot Critical Access Hospital • Medication reconciliation process • Physician and nurse driven • 2 to 3 errors per each • Follow-up by pharmacy • Clarify and correct errors • Time intensive • Increased safety risk • Omissions • Delays and duplications

  27. Demonstration Pilot Critical Access Hospital • Develop criteria for consultation • Greater than 10 scheduled medications • High-alert medications • Anticoagulants • Core-measure disease states

  28. MEDICAL WASTE REDUCTION

  29. PHARMACEUTICAL WASTE STREAMS • INCOMPATIBLE HAZARDOUS • WASTE • Aerosols • Inhalers • Oxidizers • Silver nitrate • SEWER • IV dextrose • Potassium • Saline • Sodium • Calcium • lactated ringers • magnesium • P-LISTED HAZARDOUS WASTE • Coumadin plus wrapper • Nicotine plus wrapper and peel • NON-HAZARDOUS RX WASTE • Antibiotics • Lidocaine • Pitocin • Heparin • HAZARDOUS WASTE • Insulin • Some vitamins and minerals • Phenylephrine CHEMO WASTE • REGULAR TRASH • Outside packaging • Empty items that once contained medication • Shipping packaging • Recycle paper, glass, plastic • SHARPS • Needles and broken ampoules • Empty syringes Smith CA. Managing Pharmaceutical Waste. Journal of the Pharmaceutical Society of Wisconsin 2002;17-22.

  30. INPATIENT MEDICAL WASTE • Save money, prevent delays and omissions • Clinical pharmacists know formulary medications • Clinical pharmacists prevent non-formulary and not-available medication orders at admission • Formulary management policies/procedures • Therapeutic interchange programs • Evaluate PAR levels for expired drugs

  31. OUTPATIENT MEDICAL WASTE • Outpatient prescribing practices • Polypharmacy • Lack of follow-up • Mail order pharmacies automatic renewals • Three month supplies • Compliance • Adherence • Persistence

  32. MEDICAL WASTE Ethics and the Environment • Controlled substance regulation • Changes from DEA • Expected in future • Vendors • Stericycle, others … • Environmentally conscious disposal

  33. DRUG SHORTAGES

  34. DRUG SHORTAGES Minimize Waste • Therapeutic interchange • Drug classes • Pharmacodynamics of medications • Superior therapeutic alternatives • Evidence based medicine • Avoid grey market distributers

  35. GREY MARKET • Receive emails for information only • Plan ahead • Keep adequate inventory levels • Medications dispensed daily • Accept small loss with expired medications • To stock adequate levels • Prevent drug shortages from reaching patient

  36. DRUG SHORTAGES • Aminophylline • Sincalade • Nalbuphine • Dextrose 25% and 50% syringes • Furosemide IV • Metoclopramide IV • Fentanyl IV • Potassium phosphate IV

  37. DRUG SHORTAGE RESOURCES

  38. FDA REGULATION

  39. PHARMACIST ROLE • Pharmacists vital part of the healthcare team • Pharmacotherapy experts • Explain how medications work in the body • Suggest therapeutic alternatives • Eliminate therapeutic duplications

  40. PHARMACIST ROLE • Avoid polypharmacy • Teach common side effects • Action for severe side effects • Ethical stewardship • Medical and financial resources

  41. PARADIGM SHIFT • PHARMACY COST CENTER

  42. RURAL HEALTH RESEARCH • Collaboration • Rural health hospitals • Payers • Obtain grant money • Research • New practice models • Demonstrate added value

  43. Lisa Anne Boothby, PharmD, BCPS Director of Pharmacy, Dukes Memorial Hospital Future of Clinical Pharmacy Practice in Rural Health

More Related